ReShape Lifesciences reported that it gained approval from the United States Patent and Trademark Office for its application entitled, "Intragastric Device (For Treating Obesity)." In the patent filings, the company described the product as a swallowable implant that expands via a balloon in the stomach to induce a feeling of fullness, helping to restrict food intake.
Related Keywords
United States , Novo Nordisk , Trademark Office , Health Care , Lifesciences Inc , Shape Lifesciences , Reshape Lifesciences , United States Patent , For Treating Obesity , Reshape Lifescience , Benzinga Pro ,
comparemela.com © 2020. All Rights Reserved.